EXANE DERIVATIVES

Institutional investor profile sourced from SEC Form 13F-HR filings, parsed and aggregated by FilingIQ.

Total AUM
$2.80B
13F filings
5
Latest filing
Oct 8, 2020

Top 10 holdings

XLE $16.48M
4.77% of AUM
EWT $12.25M
3.55% of AUM
TUR $10.61M
3.07% of AUM
MCHI $9.26M
2.68% of AUM
EWM $7.69M
2.23% of AUM
MSFT $6.88M
1.99% of AUM
MRK $6.19M
1.79% of AUM
EZA $5.87M
1.70% of AUM
PYPL $5.69M
1.65% of AUM
AMZN $5.49M
1.59% of AUM

About this filer

FilingIQ has indexed 5 quarterly Form 13F filings from EXANE DERIVATIVES. Reported assets under management total $2.80B.

View live EXANE DERIVATIVES filings on FilingIQ Raw 13F on SEC EDGAR

Frequently asked

How much does EXANE DERIVATIVES have under management?
Per EXANE DERIVATIVES's most recent SEC Form 13F filing dated Oct 8, 2020, total assets under management are $2.80B. 13F filings cover long-only equity positions above the SEC reporting threshold.
How many 13F filings has EXANE DERIVATIVES submitted?
FilingIQ has indexed 5 quarterly Form 13F filings from EXANE DERIVATIVES. Filings are due 45 days after quarter-end.
Where does EXANE DERIVATIVES's holdings data come from?
Every position shown on this page sources back to EXANE DERIVATIVES's public SEC Form 13F-HR filing. The raw filing is on EDGAR at the link below. FilingIQ normalizes ticker mapping and computes percent-of-AUM at filing date.

Methodology & sources

All 13F data parsed from public SEC Form 13F-HR XML filings. AUM is the sum of reported position values at filing date. See methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.